Previous 10 | Next 10 |
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, Executive V.P. of Corporate Administration Center, will participate in an Analyst-Moderated fireside chat at the 2022 Jefferies L...
On November 3, 2022, Amphastar's ( NASDAQ: AMPH ) board authorized a $50 million increase to the company's share buyback program, which is expected to continue for an indefinite period of time. The timing and actual number of shares repurchased will depend on a variety of ...
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2022 Results Conference Call November 07, 2022 05:00 PM ET Company Participants Dan Dischner - Vice President, Corporate Communications Bill Peters - Chief Executive Officer Dan Dischner - Vice President of Corporate Comm...
Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q3 Non-GAAP EPS of $0.38 misses by $0.01 . Revenue of $120.13M (+7.1% Y/Y) misses by $6.27M . Shares -8.3% . For further details see: Amphastar Pharmaceuticals Non-GAAP EPS of $0.38 misses ...
Reports Net Revenues of $120.1 Million for the Three Months Ended September 30, 2022 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 7, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2022. ...
Amphastar Pharmaceuticals ( NASDAQ: AMPH ) is scheduled to announce Q3 earnings results on Monday, November 7th, after market close. The consensus EPS Estimate is $0.39 (-15.2% Y/Y) and the consensus Revenue Estimate is $126.4M (+12.7% Y/Y). Over the last 2 years, AMPH...
Summary Two new Breakout Stocks for Week 44 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +112.8% YTD. This week two stocks gained 10% in less than a week with MAG +11.5% and WTTR +10% while another high frequency breakout...
RANCHO CUCAMONGA, CA / ACCESSWIRE / October 28, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2022 ended September 30, 2022, after the market closes on Monday, November 7, 2022, and will hold a conference call to...
Summary Amphastar's profitability and cash flow have been increasing consistently, and with management's efforts, profitability will increase significantly. Having a solid financial position and consistent growth will eventually lead to a more sustainable business model, and in su...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Back in August, I made the argument why now’s the right time to buy safe stocks . Just over a month later, this continues to be the case. The volatility and uncertainty that has rocked the stock market so far in 202...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...